№ files_lp_3_process_7_005862
Comparative pharmaceutical research study examining the equivalence of a modified single-stage impactor and pharmacopeial cascade impactors for measuring fine particle dose below 5 µm in dry powder and pressurized metered dose inhalers.
Authors: Patrik Andersson; Simon Åslund; Marcus Skogevall; Stina Sjödin; Iain Fraser; Bodil Hakonen; Jan Olof Svensson
Affiliations: Inhalation Product Development, Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden; Chalmers University, Division of Chemistry and Biochemistry, Gothenburg, Sweden
Organization: AstraZeneca; Chalmers University
City: Gothenburg; Mölndal
Country: Sweden
Type of document: Scientific research article
Subject: Determination of fine particle dose <5 µm in Dry Powder Inhalers and pressurized Metered Dose Inhalers
Equipment studied: Refined-Fast Screening Impactor (R-FSI); Fast Screening Impactor (FSI); Next Generation Impactor (NGI); Andersen Cascade Impactor (ACI)
Products investigated: Multidose Dry Powder Inhaler; Combination product pressurized Metered Dose Inhaler
Methodology: Comparative impactor measurements with interpolation algorithms (Log-Linear and Log-Probit)
Measured parameter: Fine Particle Dose (FPD<5 µm); Fine Particle Fraction (FPF)
Analytical technique: UHPLC with internal standard methodology
Purpose: Evaluation of equivalence between R-FSI and pharmacopeial cascade impactors for QC-release testing
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.